Check-Cap(CHEK) - 2022 Q1 - Quarterly Report

Exhibit 99.1 Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel, April 7, 2022 -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparationfree screening test to detect polyps before they may transform into colorectal cancer (CRC), toda ...